← Open Payments lookup

KELLY HOOVER: Open Payments

NPI 1366809923 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,486 in 197 payments from 16 companies in 2025. Trend: 2023 $2,712 · 2024 $3,001 · 2025 $3,486

Food & beverage: $3,375Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$642
Vanda Pharmaceuticals Inc.22$404
Alkermes, Inc.24$386
Teva Pharmaceuticals USA, Inc.17$356
E.R. Squibb & Sons, L.L.C.16$340
ABBVIE INC.22$316
Otsuka America Pharmaceutical, Inc.19$268
Janssen Pharmaceuticals, Inc9$174
Lundbeck LLC13$172
Supernus Pharmaceuticals, Inc.6$141

Products named: CAPLYTA, ARISTADA, COBENFY, VRAYLAR, REXULTI, HETLIOZ, FANAPT, Qelbree.

Industry payments across NE — which companies pay providers there.